Siemens contributes to King's research project June 24, 2016 -- Siemens Healthineers recently installed a Somatom Force CT system at the King's Health Partners Academic Health Sciences Centre in the U.K. to aid in imaging research.
RCR unveils 10-year training strategy June 24, 2016 -- The U.K. Royal College of Radiologists (RCR) has proposed a plan to train radiologists and grow the profession over the next 10 years.
Median teams with Microsoft for imaging analytics June 23, 2016 -- French imaging software developer Median Technologies and Microsoft have formed a joint global initiative to apply big-data analytics for processing and analyzing medical images.
NHS England expands radiotherapy services June 22, 2016 -- The U.K. Royal College of Radiologists (RCR) has commended the award of new contracts for stereotactic radiosurgery and radiotherapy services for the next seven years by National Health Service (NHS) England.
Andalusia reaps financial benefits of PACS June 22, 2016 -- A PACS developed by Carestream Health and partner Accenture has saved Spain's Andalusian Health Service (SAS) 1.5 million euros over the first 15 months of its implementation, the vendor said. Furthermore, the service can yield additional annual savings of 65% over the coming years, Carestream noted.
Mobile phones are 'hotbeds' of viruses June 22, 2016 -- Mobile phones used by hospital staff are 'hotbeds' of pathogenic viruses, according to a study conducted by researchers at the University Hospital of Saint-étienne in France and published in the journal Clinical Microbiology and Infection.
Agfa to highlight Hexalis at Paris event June 22, 2016 -- Agfa HealthCare plans to demonstrate its Hexalis lab information system at the upcoming Journées Internationales de Biologie/Colloque National des Biologistes meeting in Paris.
New radiotherapy technique trumps current standard June 21, 2016 -- A shorter course of prostate cancer radiotherapy, involving fewer hospital visits and higher individual doses of radiotherapy, is just as effective as the current standard treatment for both survival and quality of life, according to a new report in the Lancet Oncology.